Lymphoma, Follicular: all 964 studies
Page 6 of 10. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.
- How First Aid Training Helps Parents of Children With Intellectual DisabilitiesCompletedNCT07054619Not applicable
- Effects of Structured Physical Activity Breaks and Free Play in Children With Mild Intellectual DisabilityCompletedNCT06943196Not applicable
- Narrative Exposure Therapy for Adults With an Intellectual DisabilityCompletedNCT06934109Not applicable
- Health Surveillance at Constructor University Bremen (CUB)Active, not recruitingNCT06899308
- Efficacy of Propofol-Ketamine and Sevoflurane in Children Undergoing Magnetic Resonance ImagingCompletedNCT06832683Not applicable
- Open, Non-comparative Study to Evaluate the Effectiveness and Safety of the Medical Device KOS® L in Correcting Moderate or Severe Nasolabial FoldsCompletedNCT06828224Not applicable
- The "Let's Talk Tech" Tool to Support Decision Making About Technology UseCompletedNCT06817122Not applicable
- Impact of Automatic Prompts in Echocardiographic Reports on Referral to CardiologyActive, not recruitingNCT06816888Not applicable
- Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin LymphomaActive, not recruitingNCT06813573Not applicable
- A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD2389CompletedNCT06812780Phase 1
- A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa ProphylaxisActive, not recruitingNCT06752850Phase 4
- A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease PatientsCompletedNCT06745583Phase 2
- A Multi-center Clinical Study of Zanubrutinib in Combination With First-line Chemoimmunotherapy in Patients With Grade 3A High-risk Follicular LymphomaActive, not recruitingNCT06742879
- Therapeutic Play in Children With Mild Intellectual DisabilityCompletedNCT06735482Not applicable
- Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog AlfaActive, not recruitingNCT06716814Phase 3
- Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's LymphomaActive, not recruitingNCT06667687Phase 1
- POC for the Treatment of Subjects With Moderate AS Using Valvosoft® Non-Invasive Ultrasound TherapyWithdrawnNCT06650839Not applicable
- 64Cu-LLP2A for Imaging Hematologic MalignanciesTerminatedNCT06636175Early Phase 1
- Clinical Trials to Evaluate Neurophysiological and Neuropsychological Effects of a Mindfulness-based InterventionCompletedNCT06618339Not applicable
- Neuromodulation of Central Sensory Integration to Improve Postural ControlCompletedNCT06610617Not applicable
- Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular LymphomaSuspendedNCT06575686Phase 2
- A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin LymphomaTerminatedNCT06561425Phase 1/2
- Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILECompletedNCT06535997
- Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic ImpairmentCompletedNCT06535399Phase 1
- Study With Mosunetuzumab and Zanubrutinib in R/R Follicular Lymphoma PatientsActive, not recruitingNCT06492837Phase 2
- Family Caregiver Online Survey (Dementia and Swallowing Difficulties)CompletedNCT06471660
- A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular LymphomaActive, not recruitingNCT06425302Phase 2
- Study to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic ImpairmentCompletedNCT06425198Phase 1
- A Study to Assess the Drug Levels of Repotrectinib in Healthy Participants and Participants With Moderate and Severe Hepatic ImpairmentCompletedNCT06352528Phase 1
- Genetically Engineered Cells (EGFRt/19-28z/IL-12 CAR T Cells) for the Treatment of Relapsed or Refractory CD19+ Hematologic MalignanciesTerminatedNCT06343376Phase 1
- A Study to Evaluate the Efficacy and Safety of Liso-cel Compared to Standard of Care in Adults With Relapsed or Refractory Follicular LymphomaWithdrawnNCT06313996Phase 3
- PD-1, LAG-3 and TIM-3 Checkpoint Blockade in DLBCLWithdrawnNCT06290622Phase 1
- Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID)Active, not recruitingNCT06285422Phase 1
- Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5Active, not recruitingNCT06284122Phase 3
- A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin LymphomaTerminatedNCT06256484Phase 1
- Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 MonotherapyCompletedNCT06236061Phase 3
- Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept StudyActive, not recruitingNCT06225232Phase 2
- Posture, Hand Functions and Sensory Processing Skills on NutritionCompletedNCT06209463
- Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular LymphomaActive, not recruitingNCT06191744Phase 3
- Neo-adjuvant Pembrolizumab as an Alternative Treatment for MMRd Uterine CancerActive, not recruitingNCT06180733Phase 2
- Cognitive Screening Made Easy for PCPs - R33 PhaseActive, not recruitingNCT06162026Not applicable
- Effect of 10 mg Xanamem on Dementia Due to Alzheimer's DiseaseActive, not recruitingNCT06125951Phase 2/3
- Hospital Register of Decompensated Heart Failure With Preserved Ejection FractionActive, not recruitingNCT06114498
- Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular LymphomaActive, not recruitingNCT06112847Phase 2
- A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular LymphomaActive, not recruitingNCT06097364Phase 3
- Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 MaintenanceActive, not recruitingNCT06070961
- A Study to Assess Efficacy and Safety of Oral Tazemetostat in Adult Participants With Relapsed/Refractory Follicular Lymphoma That Does Not Have an "EZH2 Gain-of-function" Genetic MutationWithdrawnNCT06068881Phase 2
- Tazemetostat and Mosunetuzumab in Untreated Follicular LymphomaActive, not recruitingNCT05994235Phase 2
- The Alkmaar MLPTI Cohort Study: Outcomes at 9 YearsCompletedNCT05990582Not applicable
- Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.CompletedNCT05962606Phase 2
- A Study to Assess Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide in Subjects With Refractory or Relapsed Non-Hodgkin's LymphomaActive, not recruitingNCT05950165Phase 1/2
- A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell LymphomasActive, not recruitingNCT05934838Phase 1
- A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late XerostomiaActive, not recruitingNCT05926765Phase 2
- A Phase I Study to Investigate the Effect of Hepatic Impairment on the PK, Safety, and Tolerability of AZD2693CompletedNCT05919069Phase 1
- Precision Medicine Approach for Early Dementia & Mild Cognitive ImpairmentCompletedNCT05894954Phase 3
- A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular LymphomaActive, not recruitingNCT05888493Phase 3
- Parsaclisib in Patients With Relapsed or Refractory Follicular LymphomaWithdrawnNCT05867030Phase 1
- A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell MalignanciesTerminatedNCT05828589Phase 1
- Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab.Active, not recruitingNCT05788081Phase 2
- Adaptation of the Uniform Data Set for Telematic AdministrationCompletedNCT05785910Not applicable
- Observational Study of People Living With HIV Treated With CD19-directed CAR T CellCompletedNCT05784415
- Glofit and Obin in Follicular Lymphoma and Marginal Zone LymphomaActive, not recruitingNCT05783596Phase 2
- Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell MalignanciesActive, not recruitingNCT05753501Phase 1
- Performance and Safety Assessment of SPRING THREAD® Elastic Tensor Thread in Patients With Mild to Moderate Facial Ptosis.Active, not recruitingNCT05746078
- Evaluation of Bariatric Endoscopic Antral Myotomy (BEAM) as a Treatment for ObesityActive, not recruitingNCT05713071Not applicable
- Study of Virtual Reality-based Medical Device for Patients with Depressive DisorderCompletedNCT05701345Not applicable
- A Rollover Study of CC-122Active, not recruitingNCT05688475Phase 1
- Event-Related Potential (ERP) Components in Clinical DiagnosisTerminatedNCT05673759
- Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic MalignanciesActive, not recruitingNCT05665062Phase 1
- ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell MalignanciesCompletedNCT05653271Phase 1
- A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)CompletedNCT05637801Not applicable
- Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted TreatmentActive, not recruitingNCT05627245Phase 1
- Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin LymphomaActive, not recruitingNCT05621096Phase 1
- Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin LymphomaTerminatedNCT05618366Phase 1
- Zandelisib + Tazemetostat in R/R Follicular LymphomaWithdrawnNCT05604417Phase 1/2
- Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or LymphomasActive, not recruitingNCT05565417Phase 1/2
- A Study of Tazemetostat With Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular LymphomaActive, not recruitingNCT05551936Phase 1/2
- Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)CompletedNCT05529524
- A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)Active, not recruitingNCT05512390Phase 1
- ProUrokinase for Mild Ischemic Cerebrovascular Events (PUMICE)CompletedNCT05507645Phase 3
- Tazemetostat for the Treatment of Relapsed/Refractory Follicular LymphomaCompletedNCT05467943Phase 2
- A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)Active, not recruitingNCT05458297Phase 2
- Loncastuximab Tesirine for the Treatment of Relapsed or Refractory B-Cell MalignanciesTerminatedNCT05453396Phase 2
- Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell LymphomaActive, not recruitingNCT05412290Phase 1
- Mosunetuzumab and Polatuzumab Vedotin for Untreated Follicular LymphomaActive, not recruitingNCT05410418Phase 2
- Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular LymphomaActive, not recruitingNCT05409066Phase 3
- A Prospective Multicenter Phase 2 Study of the Chemotherapy-Free Combination of the Intravenous Phosphatidylinositol-3-Kinase (PI3K) Inhibitor Copanlisib in Combination With Obinutuzumab in Patients With Previously Untreated Follicular Lymphoma (FL) and a High Tumor BurdenActive, not recruitingNCT05387616Phase 2
- Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular LymphomaActive, not recruitingNCT05371093Phase 3
- Braining- Aerobic Physical Activity as Add on Treatment in Bipolar DepressionSuspendedNCT05340686Not applicable
- Real-World Clinical Outcomes in Adult Patients Who Initiate Systemic Treatment for Relapsed or Refractory Follicular LymphomaCompletedNCT05338879
- A Study of CNTY-101 in Participants With CD19-Positive B-Cell MalignanciesTerminatedNCT05336409Phase 1
- A Phase II Trial of Intermediate Radiation Dose For LymphomaStatus unknownNCT05284825Not applicable
- Loncastuximab Tesirine in Combination With Chemotherapy Prior to Stem Cell Transplant for the Treatment of Recurrent or Refractory Diffuse Large B-Cell LymphomaWithdrawnNCT05228249Phase 1
- A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 (EZH2) Gene Mutation in JapanActive, not recruitingNCT05228158
- Objective and Perceived Health Status of Elderly People With Moderate or Severe Haemophilia in France: an Ancillary Study of the FranceCoag RegistryCompletedNCT05218772
- HMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/SLL or NHLWithdrawnNCT05176691Phase 1
- A Study of bbT369 in Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma (NHL)TerminatedNCT05169489Phase 1
- Tazemetostat in Combination With Umbralisib and Ublituximab for the Treatment Relapsed or Refractory Follicular LymphomaWithdrawnNCT05152459Phase 1/2
- Evolut™ EXPAND TAVR II Pivotal TrialActive, not recruitingNCT05149755Not applicable
- PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell MalignanciesTerminatedNCT05107856Phase 1